BamSEC and AlphaSense Join Forces
Learn More

ACADIA Pharmaceuticals Inc. – Material Contracts

NASDAQ: ACAD    
Share price (6/2/26): $20.89    
Market cap (6/2/26): $3.577 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 27 pages ACADIA Pharmaceuticals Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: April 10, 2024 Approved by the Stockholders: May 29, 2024 Amended by the Board of Directors: April 14, 2026 Approved by the Stockholders: May 29, 2026
12/34/56
EX-10.1
from 10-Q 5 pages ACADIA Pharmaceuticals Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.53
from 10-K 37 pages Master Commercial Manufacturing Services Agreement
12/34/56
EX-10.52
from 10-K 42 pages Commercial Supply Agreement
12/34/56
EX-10.25
from 10-K 19 pages Registration Rights Agreement
12/34/56
EX-10.5
from 10-Q 11 pages ACADIA Pharmaceuticals Inc. Psu Award Grant Notice
12/34/56
EX-10.4
from 10-Q 11 pages ACADIA Pharmaceuticals Inc. Psu Award Grant Notice
12/34/56
EX-10.3
from 10-Q 5 pages Amendment No. 1 to Lease and Lease Agreement
12/34/56
EX-10.2
from 10-Q 81 pages Lease and Lease Agreement Between 210 Associates Limited Partnership the Landlord and ACADIA Pharmaceuticals Inc. the Tenant for Leased Premises in 210 Carnegie Center Princeton, New Jersey May 15, 2025
12/34/56
EX-10.1
from 10-Q 5 pages ACADIA Pharmaceuticals Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.43
from 10-K 52 pages Asset Purchase Agreement by and Between [***] and ACADIA Pharmaceuticals Inc. November 5, 2024
12/34/56
EX-10.31
from 10-K 119 pages One Paseo Office Lease
12/34/56
EX-10.30
from 10-K 58 pages Certain Confidential Information Contained in This Document, Marked by […***…], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.16
from 10-K 9 pages Certain Confidential Information Contained in This Document, Marked by […***…], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. November 15, 2024 Thomas Garner […***…]
12/34/56
EX-10.6
from 10-Q 11 pages ACADIA Pharmaceuticals Inc. Psu Award Grant Notice
12/34/56
EX-10.2
from 8-K 9 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 9 pages ACADIA Pharmaceuticals Inc. Executive Transition Agreement
12/34/56
EX-10.9
from 10-Q 5 pages February 22, 2024 Equity Award: A)
12/34/56
EX-10.3
from 10-Q 18 pages Acadia Pharmaceuticals Inc. Performance Stock Unit Grant Notice
12/34/56
EX-10.2
from 10-Q 11 pages Acadia Pharmaceuticals, Inc. Restricted Stock Unit Grant Notice
12/34/56